Leucadia National Corporation »

Bridgebio Pharma shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.7M 1.5M 1.12
2023-09-30 $101k 135k 0.75

More positions owned by Leucadia National Corporation

Spdr Gold Tr Gold Shs (GLD)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Series Trust State Street Spd (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Select Sector Spdr Tr State Street Ene (XLE)
Amazon (AMZN)
Iren Ordinary Shares (IREN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
NVIDIA Corporation (NVDA)
Wal-Mart Stores (WMT)
Mastercard Incorporated Cl A (MA)
Ashland (ASH)
Broadcom (AVGO)
Meta Platforms Cl A (META)

View all positions for Leucadia National Corporation

Top funds holding Bridgebio Pharma

Linden Advisors
Ing Investment Management
Context Capital Management
MacKay Shields
Lord, Abbett & Co
Wolverine Asset Management
Polar Capital Holdings
Silverback Asset Management
Laurion Capital Management
Advent Capital Management
State Street Corporation
BlackRock
Wells Fargo & Company
FMR
OZ Management

View all funds holding Bridgebio Pharma